Clinical Trials Browser

Interventional × Rhabdoid Tumor × Nivolumab × Clear all

NCT05407441 2026-04-13

Tazemetostat+Nivo/Ipi in INI1-Neg/SMARCA4-Def Tumors

Phase 1/2 Active not recruiting

Chordoma, Sarcoma, Rhabdoid Tumor

NCT06622941 2026-03-12

Study to ONO-4538 in Patients With Rhabdoid Tumor

Phase 2 Recruiting

Rhabdoid Tumor

NCT04416568 2025-12-17

Study of Nivolumab and Ipilimumab in Children and Young Adults With INI1-Negative Cancers

Phase 2 Active not recruiting

Chordoma, Sarcoma, Rhabdoid Tumor